Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
Year: 2001
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: N C Levitt, F A Eskens, K J O'Byrne, D J Propper, L J Denis, S J Owen, L Choi, J A Foekens, S Wilner, J M Wood, M Nakajima, D C Talbot, W P Steward, A L Harris, J Verweij
Institution: Churchill Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2128938772